Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | TEAD1 | P28347 | 1/20 | 0.33 |
| ▸ | YAP1 | P46937 | 1/20 | 0.33 |
| ▸ | TEAD4 | Q15561 | 1/20 | 0.33 |
| ▸ | TEAD2 | Q15562 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31174132 | 0.83 | CA2 (0.36) | CA2CA9 | |
| SCHEMBL13787276 | 0.83 | CA2 (0.36) | CA2CA9 | |
| SCHEMBL16800946 | 0.81 | MEN1 (0.52) | CA2CA9 | |
| SCHEMBL23662885 | 0.81 | CA2 (0.35) | ALDH1A1CA2CA9 | |
| SCHEMBL31413665 | 0.81 | CA2 (0.38) | CA2CA9 | |
| SCHEMBL14308916 | 0.79 | CA2 (0.32) | CA2CA9 | |
| SCHEMBL18845128 | 0.78 | HDAC3 (0.36) | ALDH1A1CA2CA9 | |
| SCHEMBL18845127 | 0.78 | CASP2 (0.50) | ALDH1A1 | |
| SCHEMBL25328127 | 0.78 | FAAH (0.46) | ALDH1A1SMN1; SMN2CA2CA9 | |
| SCHEMBL14285708 | 0.78 | CA2 (0.36) | CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114127974-B | Markers for labeling biomolecules | 上海宸安生物科技有限公司 | 2023-04-18 | — | — | CN | disclosed |
| US-20220146518-A1 | TAG FOR LABELING BIOMOLECULES | SHANGHAI POLARIS BIOLOGY CO., LTD. (CN) | 2022-05-12 | — | — | US | disclosed |
| EP-3970208-A1 | A TAG FOR LABELING BIOMOLECULES | Shanghai Polaris Biology Co., Ltd. (CN) | 2022-03-23 | — | — | EP | disclosed |
| CN-114127974-A | Markers for labeling biomolecules | 上海宸安生物科技有限公司 | 2022-03-01 | — | — | CN | disclosed |
| WO-2020228734-A1 | A TAG FOR LABELING BIOMOLECULES | SHANGHAI POLARIS BIOLOGY CO., LTD. (CN) | 2020-11-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220146518-A1 | TAG FOR LABELING BIOMOLECULES | BTD, DNPEP, ALB | ALDH1A1 1138/4885SMN1; SMN2 4609/4885CA2 4131/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.